These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 4074466)
1. Effects of pantethine on in-vitro peroxidation of low density lipoproteins. Bon GB; Cazzolato G; Zago S; Avogaro P Atherosclerosis; 1985 Oct; 57(1):99-106. PubMed ID: 4074466 [TBL] [Abstract][Full Text] [Related]
2. Indications for the presence of circulating peroxidized low density lipoproteins in WHHL rabbits treated with antioxidants. Demacker PN; Hijmans AG; Kleinveld HA; Stalenhoef AF Atherosclerosis; 1993 Aug; 102(1):69-77. PubMed ID: 8257454 [TBL] [Abstract][Full Text] [Related]
3. Effect of probucol, pantethine and their combinations on serum lipoprotein metabolism and on the incidence of atheromatous lesions in the rabbit. Tawara K; Ishihara M; Ogawa H; Tomikawa M Jpn J Pharmacol; 1986 Jun; 41(2):211-22. PubMed ID: 3747267 [TBL] [Abstract][Full Text] [Related]
4. Modulation of HMG-CoA reductase activity by pantetheine/pantethine. Cighetti G; Del Puppo M; Paroni R; Galli Kienle M Biochim Biophys Acta; 1988 Nov; 963(2):389-93. PubMed ID: 3196742 [TBL] [Abstract][Full Text] [Related]
5. The effects of pantethine on lipid and lipoprotein abnormalities in survivors of cerebral infarction. Murai A; Miyahara T; Tanaka T; Sako Y; Nishimura N; Kameyama M Artery; 1985; 12(4):234-43. PubMed ID: 3935096 [TBL] [Abstract][Full Text] [Related]
7. Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages. Hoff HF; O'Neil J Atherosclerosis; 1988 Mar; 70(1-2):29-41. PubMed ID: 3355615 [TBL] [Abstract][Full Text] [Related]
8. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cell. I. Chemical modifications of ultraviolet-treated low-density lipoproteins. Dousset N; Negre-Salvayre A; Lopez M; Salvayre R; Douste-Blazy L Biochim Biophys Acta; 1990 Aug; 1045(3):219-23. PubMed ID: 2386793 [TBL] [Abstract][Full Text] [Related]
9. Pantethine, a derivative of vitamin B(5) used as a nutritional supplement, favorably alters low-density lipoprotein cholesterol metabolism in low- to moderate-cardiovascular risk North American subjects: a triple-blinded placebo and diet-controlled investigation. Rumberger JA; Napolitano J; Azumano I; Kamiya T; Evans M Nutr Res; 2011 Aug; 31(8):608-15. PubMed ID: 21925346 [TBL] [Abstract][Full Text] [Related]
10. Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein. Lynch SM; Campione AL; Moore MK Biochim Biophys Acta; 2000 May; 1485(1):11-22. PubMed ID: 10802245 [TBL] [Abstract][Full Text] [Related]
11. Effect of pantethine on the biosynthesis of cholesterol in human skin fibroblasts. Ranganathan S; Jackson RL; Harmony JA Atherosclerosis; 1982 Sep; 44(3):261-73. PubMed ID: 7150392 [TBL] [Abstract][Full Text] [Related]
12. Pantethine inhibits cholesterol and fatty acid syntheses and stimulates carbon dioxide formation in isolated rat hepatocytes. Cighetti G; Del Puppo M; Paroni R; Fiorica E; Galli Kienle M J Lipid Res; 1987 Feb; 28(2):152-61. PubMed ID: 3106549 [TBL] [Abstract][Full Text] [Related]
13. The mechanism of apolipoprotein B-100 thiol depletion during oxidative modification of low-density lipoprotein. Ferguson E; Singh RJ; Hogg N; Kalyanaraman B Arch Biochem Biophys; 1997 May; 341(2):287-94. PubMed ID: 9169017 [TBL] [Abstract][Full Text] [Related]
14. Effect of pantethine on fatty acid oxidation in microvessels of rat brain. Morisaki N; Matsuoka N; Shirai K; Sasaki N; Saito Y; Kumagai A Tohoku J Exp Med; 1983 Sep; 141(1):41-5. PubMed ID: 6636148 [TBL] [Abstract][Full Text] [Related]
15. Antioxidants selenomethionine and D-pantethine decrease the negative side effects of doxorubicin in NL/Ly lymphoma-bearing mice. Panchuk RR; Skorokhyd NR; Kozak YS; Lehka LV; Chumak VV; Omelyanchik SN; Gurinovich VA; Moiseenok AG; Stoika RS Croat Med J; 2016 Apr; 57(2):180-92. PubMed ID: 27106359 [TBL] [Abstract][Full Text] [Related]
16. Effects of pantethine on action potential of canine papillary muscle during hypoxic perfusion. Hayashi H; Kobayashi A; Terada H; Nagao B; Nishiyama T; Kamikawa T; Yamazaki N Jpn Heart J; 1985 Mar; 26(2):289-96. PubMed ID: 4009970 [TBL] [Abstract][Full Text] [Related]
17. Role of endothelial cells and their products in the modification of low-density lipoproteins. van Hinsbergh VW; Scheffer M; Havekes L; Kempen HJ Biochim Biophys Acta; 1986 Aug; 878(1):49-64. PubMed ID: 3730414 [TBL] [Abstract][Full Text] [Related]
18. Changes in oxytocin and vasopressin content in posterior pituitary and hypothalamus following pantethine treatment. Ong GL; Miaskowski C; Haldar J Life Sci; 1990; 47(6):503-6. PubMed ID: 2402177 [TBL] [Abstract][Full Text] [Related]
19. Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice. Hayek T; Oiknine J; Brook JG; Aviram M Biochem Biophys Res Commun; 1994 Jun; 201(3):1567-74. PubMed ID: 8024602 [TBL] [Abstract][Full Text] [Related]
20. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. Esterbauer H; Jürgens G; Quehenberger O; Koller E J Lipid Res; 1987 May; 28(5):495-509. PubMed ID: 3598395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]